These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1427 related items for PubMed ID: 19895779

  • 21. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V, Miodownik C, Gibel A, Sirota P, Bush I, Elliot H, Benatov R, Ritsner MS.
    J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia.
    Majadas S, Olivares J, Galan J, Diez T.
    Compr Psychiatry; 2012 Feb; 53(2):145-51. PubMed ID: 21621754
    [Abstract] [Full Text] [Related]

  • 23. Considering DSM-5: personality diagnostics in patients with schizophrenia spectrum disorders.
    Schroeder K, Hoppe A, Andresen B, Naber D, Lammers CH, Huber CG.
    Psychiatry; 2012 Feb; 75(2):120-34. PubMed ID: 22642432
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
    Ichioka S, Terao T, Hoaki N, Matsushita T, Hoaki T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):170-4. PubMed ID: 22750309
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
    Kitajima R, Miyamoto S, Tenjin T, Ojima K, Ogino S, Miyake N, Fujiwara K, Funamoto Y, Arai J, Tsukahara S, Ito Y, Tadokoro M, Anai K, Kaneda Y, Yamaguchi N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar 30; 36(2):300-6. PubMed ID: 22122880
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia.
    Kopelowicz A, Zarate R, Tripodis K, Gonzalez V, Mintz J.
    Am J Psychiatry; 2000 Jun 30; 157(6):987-93. PubMed ID: 10831481
    [Abstract] [Full Text] [Related]

  • 36. Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia.
    Docherty JP, Baker RA, Eudicone J, Mathew S, Marcus RN, McQuade RD, Mankoski R.
    Schizophr Res; 2010 Jul 30; 120(1-3):199-203. PubMed ID: 20547037
    [Abstract] [Full Text] [Related]

  • 37. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
    Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC.
    J Clin Psychiatry; 2004 Oct 30; 65(10):1372-6. PubMed ID: 15491241
    [Abstract] [Full Text] [Related]

  • 38. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.
    Kelley ME, van Kammen DP, Allen DN.
    Am J Psychiatry; 1999 Mar 30; 156(3):406-11. PubMed ID: 10080556
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 72.